Pancreatic Cancer Clinical Trials in Houston

Showing 141-145 of 145 trials

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

NCT00014651

RATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection. It is not yet known if vapreotide is more effective than no further therapy in preventing side effects of pancreatic resection. PURPOSE: This randomized phase III trial is studying vapreotide to see how well it works compared to a placebo in preventing complications in patients undergoing surgery for pancreatic cancer.

Pancreatic CancerPerioperative/Postoperative Complications

Mayo ClinicStarted Mar 2001

Birmingham, Alabama, United States • Tampa, Florida, United States • Chicago, Illinois, United States +15 more locations

COMPLETEDPhase 2< 1 mile

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

NCT00222469

The purpose of this study is to find out if giving patients bevacizumab along with the chemotherapy drugs oxaliplatin and gemcitabine will improve overall survival. In addition, the study will find out what side effects patients may have by taking bevacizumab, oxaliplatin, and gemcitabine together.

Metastatic Pancreatic Cancer

University of Oklahoma50 participantsStarted Aug 2005

Oklahoma City, Oklahoma, United States • Houston, Texas, United States

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

Pancreatic Cancer Trials in Other Cities

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Other Conditions in Houston